Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Department of Hematology, Rigshospitalet.

During the past decade, Department of Hematology, Rigshospitalet conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Hematology, Rigshospitalet" #1 sponsor was "Nordic MDS Group" with 3 trials, followed by "Henrik Gregersen" with 2 trials sponsored, "Jens Rikardt Andersen" with 2 trials sponsored, "Mats Heyman" with 2 trials sponsored and "Nordic Lymphoma Group" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Rigshospitalet" #1 collaborator was "Danish Child Cancer Foundation" with 2 trials as a collaborator, "Danish Myeloma Study Group" with 2 trials as a collaborator, "NordForsk" with 2 trials as a collaborator, "Nordic Society for Pediatric Hematology and Oncology" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology, Rigshospitalet" are "Leukemia, Acute Lymphoblastic" (2 trials), "MDS" (2 trials), "Multiple Myeloma" (2 trials), "AML" (1 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Department of Hematology, Rigshospitalet" in a lesser frequency.

Most popular intervention types in "Department of Hematology, Rigshospitalet" are "Drug" (11 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin" (2 trials), "Venetoclax" (2 trials), "6-tioguanine+Standard Maintenance Therapy" (1 trials), "AG-946" (1 trials) and "AG-946 Matched Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology, Rigshospitalet" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology, Rigshospitalet". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Department of Hematology, Rigshospitalet, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology, Rigshospitalet, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".